Dual GIP/GLP-1 receptor agonist research peptide.
Tirzepatide is a dual GIP/GLP-1 receptor agonist evaluated in research for combined incretin pathway activation.
Co-activation of GIP and GLP-1 receptors has been observed in vitro to produce additive effects on insulin sensitivity markers in research models.
Bulk: Buy 3, get 1 free
Kits (10 vials): Contact for pricing.
| Size | 20mg, 40mg |
|---|
Important Legal Notice — Please Read
The compounds offered on this website are sold strictly for in-vitro laboratory research use only by qualified researchers. They are not intended to diagnose, treat, cure, or prevent any disease, and are not for human or animal consumption.
By entering this site you confirm that you are at least 21 years of age, that you understand these terms, and that you have a legitimate research basis for purchasing these compounds.
All compounds are sold individually. Research supplies (bacteriostatic water, syringes) are not included. Most products ship as lyophilized powder and require reconstitution with a suitable diluent prior to research use.
Reviews
There are no reviews yet.